crown

Subscribe Now

FOLLOW US

Sign in

Novavax News

Serum Institute of India to produce 5mn Covishield doses in two months

Adar Poonawalla, chief executive officer of Serum Institute of India (SII). (HT PHOTO)

Updated 1179 days ago

Novavax 2022 Covid vaccine deliveries off to slow start, shares drop

It sold 31 million doses of the vaccine in the quarter, a small fraction of the 2 billion shots it plans to send around the world in 2022.

Updated 1527 days ago

WHO experts recommend 3rd dose of Novavax vaccine for people with health issues

After reviewing Novavax data the independent experts said the vaccine could be used in pregnant women if the benefits of vaccination to the pregnant woman outweigh the potential risks.

Updated 1666 days ago

Novavax Covid jab gets EU medicine regulator's approval

Novavax uses tiny, lab-made fragments of a protein found on the surface of the coronavirus spike.

Published 1667 days ago

Serum Institute to launch Covovax jab for kids in 6 months, says Adar Poonawalla

Adar Poonawalla (File Photo)

Published 1674 days ago

Novavax COVID-19 vaccine receives its first emergency use authorization

Indonesia approves Novavax's Covid-19 vaccine for emergency use.

Updated 1716 days ago

‘Can’t launch vaccine till…’: Serum MD talks of issues between FDA and Novavax

Published 1796 days ago

J&J and Novavax seek approval for vaccines

Health workers visit the remote Mamgund Gonipora village of Budgam district to vaccinate local residents, on Friday. (PTI)

Updated 1803 days ago

'Hope to launch Covavax for adults in Oct, early 2022 for kids': Adar Poonwalla

Adar Poonawalla (File photo)

Published 1803 days ago

‘Great potential’: Serum Institute begins production of 1st Covovax batch

"Excited to witness the first batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune," SII CEO Adar Poonawalla tweeted.

Published 1845 days ago

SII manufactures first batch of Covavax vaccine; Poonawalla congratulates team

Adar Poonawalla surveying the Covavax manufacturing process at the SII plant.

Published 1845 days ago

Serum Institute of India likely to start Covovax trials on kids by July

SII’s CEO Adar Poonawalla had earlier said that the vaccine could be launched in India by September, subject to the grant of necessary regulatory clearances.

Published 1853 days ago

Biological E’s vaccine efficacy same as Novavax: Government panel chief

On Monday, Novavax announced that NVX-CoV2373, its recombinant nanoparticle protein-based Covid-19 vaccine

Updated 1853 days ago

SII to introduce Novavax vaccine in India by September: Report

Novavax showed 93% effectiveness against variants of concern based on test results from a secondary analysis which mostly consisted of cases of the alpha variant which is predominant in the United States.

Published 1853 days ago

Shortage of raw material holding up Covovax manufacturing

SII is the manufacturing partner for Novavax in India

Updated 1854 days ago

Novavax vaccine efficacy data promising; trials in advanced stage: Centre

The government on Tuesday said the efficacy data of Novavax vaccine against Covid-19 was promising and encouraging.

Published 1855 days ago

Novavax vaccine 90% effective against Covid-19, says US firm

The latest clinical trial included 30,000 participants.

Updated 1856 days ago

Novavax combined influenza/Covid-19 vaccine shows promise in animal study

Published 1891 days ago

Novavax starts Covid-19 vaccine trials on children

The Novavax vaccine has not yet been authorized in any country, including for adults, but the company plans to file for emergency authorization in Britain "in the second quarter of 2021", followed by in the United States.

Published 1898 days ago

Novavax says supply shortages delaying production of its Covid-19 vaccine

Novavax could receive UK regulatory authorization for its vaccine as early as this month after releasing impressive UK trial data.

Published 1918 days ago

Wall Street bets Moderna, Novavax will finally fall in 2021

FILE - In this Nov. 5, 2020 file photo, a sign for Wall Street is carved in the side of a building. Stocks are opening higher on Wall Street led by gains in Big Tech companies. The S&P 500 was up 0.4% early Wednesday, March 31, 2021.

Published 1926 days ago

SII begins phase 2/3 trials for Covovax, supply likely by Sept

“Covovax trials finally begin in India," SII CEO Adar Poonawalla tweeted.

Updated 1935 days ago

Now, SII seeks trial approval for Novavax Covid vaccine

SII has applied to India’s drugs controller for permission to conduct a small bridging study for Novavax’s Covid-19 vaccine candidate.

Published 1991 days ago

Home / Topic / Novavax / News

© 2026 HindustanTimes